Qualigen Therapeutics Inc (QLGN) Stock Analysis

Qualigen Therapeutics Inc (QLGN) is a publicly traded company in the HEALTHCARE sector. It trades at $1.31. This page summarizes the public market data, fundamentals, and frequently asked questions for QLGN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

About Qualigen Therapeutics Inc

Qualigen Therapeutics Inc. is an innovative biotechnology firm based in Carlsbad, California, focused on developing novel therapeutic solutions to combat cancer and infectious diseases. Leveraging cutting-edge science and technology, the company aims to address unmet medical needs with its pipeline of potential products. Qualigen is committed to improving patient outcomes through advancements in targeted therapies and diagnostics, positioning itself as a key player in the biopharmaceutical la...

GNG Research Analysis

GNG Research scores Qualigen Therapeutics Inc (QLGN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for QLGN.

Frequently Asked Questions

Does QLGN pay dividends?

Qualigen Therapeutics Inc (QLGN) does not currently pay a regular dividend.